Author:
Scatena Caroline D.,Kumer Jeffrey L.,Arbitrario Jennifer P.,Howlett Anthony R.,Hawtin Rachael E.,Fox Judith A.,Silverman Jeffrey A.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference33 articles.
1. Advani RH, Hurwitz HI, Gordon MS, Ebbinghaus SW, Mendelson DS, Wakelee HA, Hoch U, Silverman JA, Havrilla NA, Berman CJ, Fox JA, Allen RS, DC A (2009) Phase 1 Experience with Voreloxin, a First in Class Anticancer Quinolone Derivative, in Relapsed/Refractory Solid Tumors: A report on two dosing schedules (Submitted)
2. Alberts DS, Bachur NR, Holtzman JL (1971) The pharmacokinetics of daunomycin in man. Clin Pharmacol Ther 12:96–104
3. Burke PJ, Karp JE, Vaughan WP (1981) Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response. J Natl Cancer Inst 67:529–538
4. Capranico G, De Isabella P, Penco S, Tinelli S, Zunino F (1989) Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in Murine Leukemia P388 cells. Cancer Res 49:2022–2027
5. Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献